
|Videos|October 11, 2016
Atopic Dermatitis: Cost and Value
Advertisement
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Jonathan Silverberg, MD, PhD, MPH; Ed Pezalla, MD, MPH; and Jeffrey D. Dunn, PharmD, MBA, provide insight on balancing the cost and benefit of treatments for atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution
2
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
3
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
4
MHT Use Can Affect Cognitive Health Depending on Administration Method
5